메뉴 건너뛰기




Volumn 96, Issue 7, 2002, Pages 548-550

Pergolide-induced lung disease in patients with Parkinson's disease

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENSERAZIDE; CARBIDOPA; CITRIC ACID; CYCLOPHOSPHAMIDE; ENTACAPONE; GLUCOCORTICOID; LEVODOPA; PERGOLIDE; PREDNISOLONE; PROTEIN;

EID: 0036656758     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1310     Document Type: Article
Times cited : (9)

References (9)
  • 1
    • 0028985322 scopus 로고
    • Drug treatment of Parkinson's disease
    • Quinn N. Drug treatment of Parkinson's disease. Br Med J 1995; 310: 575-579.
    • (1995) Br. Med. J , vol.310 , pp. 575-579
    • Quinn, N.1
  • 2
    • 0027500750 scopus 로고
    • Treatment of Parkinson's disease
    • Calne DB. Treatment of Parkinson's disease. N Engl J Med 1993; 329: 1021-1027.
    • (1993) N. Engl. J. Med , vol.329 , pp. 1021-1027
    • Calne, D.B.1
  • 4
    • 18244411921 scopus 로고    scopus 로고
    • Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease
    • Kunkler RB, Osborn DE, Abbott RJ. Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease. Br J Urol 1998; 82: 147.
    • (1998) Br. J. Urol , vol.82 , pp. 147
    • Kunkler, R.B.1    Osborn, D.E.2    Abbott, R.J.3
  • 5
    • 0029021910 scopus 로고
    • Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide
    • Jimenez-Jimenez FJ, Lopez-Alvarez J, Sanchez-Chapado M, et al. Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide. Clin Neuropharmacol 1995; 18: 277-279.
    • (1995) Clin. Neuropharmacol , vol.18 , pp. 277-279
    • Jimenez-Jimenez, F.J.1    Lopez-Alvarez, J.2    Sanchez-Chapado, M.3
  • 6
    • 0003559922 scopus 로고
    • Diseases characterised primarily by increased lung opacity
    • Webb WR, Muller NL, Naidich DP (eds). New York: Raven Press
    • Webb WR, Muller NL, Naidich DP. Diseases characterised primarily by increased lung opacity. In: Webb WR, Muller NL, Naidich DP (eds). High-Resolution CT of the Lung New York: Raven Press, 1992: 88-110.
    • (1992) High-Resolution CT of the Lung , pp. 88-110
    • Webb, W.R.1    Muller, N.L.2    Naidich, D.P.3
  • 7
    • 0033661926 scopus 로고    scopus 로고
    • Capsaicin induced cough in cryptogenic fibrosing alveolitis
    • Doherty MD, Mister R, Pearson MG, Calverley PM. Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax 2000; 55: 1028-1032.
    • (2000) Thorax , vol.55 , pp. 1028-1032
    • Doherty, M.D.1    Mister, R.2    Pearson, M.G.3    Calverley, P.M.4
  • 8
    • 0031949539 scopus 로고    scopus 로고
    • Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease
    • Lalloo UG, Lim S, DuBois R, Barnes PJ, Chung KF. Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. Eur Respir J 1998; 11: 702-705.
    • (1998) Eur. Respir. J , vol.11 , pp. 702-705
    • Lalloo, U.G.1    Lim, S.2    DuBois, R.3    Barnes, P.J.4    Chung, K.F.5
  • 9
    • 0016859949 scopus 로고
    • Adverse drug reactions: A critical review
    • Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA 1975; 234: 1236-1241.
    • (1975) JAMA , vol.234 , pp. 1236-1241
    • Karch, F.E.1    Lasagna, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.